💉 RETATRUTIDE – 15 MG KIT – 15 MG / VIAL – 1 VIAL – ZPHC PHARMA
💉 Product Type
Peptide / Multi-Agonist Hormonal Therapy / Injectable
💉 Active Ingredient
Retatrutide
💉 Dosage Form
Vial 💉
💉 Description
Retatrutide 15 MG from ZPHC Pharma is a next-generation multi-agonist peptide that targets GLP-1, GIP, and glucagon receptors.
This peptide is designed for advanced research in weight management, metabolic optimization, and type 2 diabetes support, providing insight into how triple agonists influence appetite regulation, insulin sensitivity, and fat metabolism.
💉 Mechanism of Action (How It Works)
- Activates GLP-1 receptors to improve satiety and glucose control
- Activates GIP receptors to enhance insulin sensitivity and lipid metabolism
- Modulates glucagon receptors for optimized energy utilization
- Supports weight loss, fat oxidation, and metabolic regulation
- Enhances overall cellular and metabolic performance
💉 Key Benefits
✅ Supports fat loss and weight management
✅ Enhances insulin sensitivity and glucose regulation
✅ Regulates appetite and energy balance
✅ Promotes metabolic efficiency and overall wellness
💉 Side Effects
⚠ Mild gastrointestinal discomfort (nausea, diarrhea)
⚠ Temporary headache or dizziness
⚠ Injection-site irritation
⚠ Potential changes in blood glucose
💉 Contraindications
❌ Pregnant or breastfeeding women
❌ Individuals with medullary thyroid carcinoma or MEN 2
❌ Severe gastrointestinal disorders
❌ Consult a healthcare provider before use
💉 Important Notes
Retatrutide 15 MG is a research-grade peptide and should be used under medical supervision.
💉 Reconstitution with bacteriostatic water and proper refrigerated storage (2–8°C) is required.
| Brands | ZPHC PHARMA |